1. Utility of Elevated Pentraxin-3 Level as Inflammatory Marker for Predicting Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis
   Yu Fan et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
2. Administration of Huperzine A microspheres ameliorates myocardial ischemic injury via α7nAChR-dependent JAK2/STAT3 signaling pathway
   Ce Zhang et al, 2023, European Journal of Pharmacology CrossRef
3. Clinical Features of Acute Coronary Syndrome in Patients with Coronary Heart Disease and Its Correlation with Tumour Necrosis Factor in Cardiology
   Run Guo et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
4. Pentraxin 3: A promising therapeutic target for cardiovascular diseases
   Xingyan Ye et al, 2024, Ageing Research Reviews CrossRef
5. Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies
   Kejun Ding et al, 2022, Frontiers in Cardiovascular Medicine CrossRef